AQR Arbitrage’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

AQR Arbitrage’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.1M	Sell	1,324,175 -88,575	-6%	-$943K	0.23%	89
2025 Q4	$15M	Hold	1,412,750	–	–	0.32%	84
2025 Q3	$14.8M	Sell	1,412,750 -38,000	-3%	-$397K	0.38%	85
2025 Q2	$15.2M	Hold	1,450,750	–	–	0.35%	81
2025 Q1	$14.8M	Sell	1,450,750 -529,535	-27%	-$5.31M	0.35%	95
2024 Q4	$19.7M	Buy	+1,980,285	New	+$19.8M	0.43%	71

Other funds holding OACC

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AQR Arbitrage's OACC Position: Q1 2026 in Review

AQR Arbitrage reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 6.3% in Q1 2026, selling an estimated $943K and leaving 1,324,175 shares worth $14.1M. The position accounts for 0.23% of the portfolio, ranked #89.

AQR Arbitrage first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. The position peaked at $19.7M in Q4 2024. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

AQR Arbitrage held 1,324,175 shares of Oaktree Acquisition Corp III Life Sciences worth $14.1M as of Q1 2026.
AQR Arbitrage sold 88,575 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $943K.
Oaktree Acquisition Corp III Life Sciences made up 0.23% of AQR Arbitrage's portfolio in Q1 2026, its #89 holding.
AQR Arbitrage first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
AQR Arbitrage's Oaktree Acquisition Corp III Life Sciences position peaked at $19.7M in Q4 2024.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.